RSCM
CNTB icon

Rock Springs Capital Management’s Connect Biopharma Holdings CNTB Stock Holding History

Rock Springs Capital Management’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-119,114
Closed -$2.2M – 159
2021
Q1 		$2.2M Buy
+119,114
New +$2.03M 0.05% 138

Other funds holding CNTB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
OWP
Old Well Partners Charlotte, North Carolina $4.55M AUM 27.75% 1-Year Est. Return

Rock Springs Capital Management's CNTB Position: Q2 2021 in Review

Rock Springs Capital Management sold out of Connect Biopharma Holdings (CNTB) in Q2 2021, closing a stake of 119,114 shares — an estimated $2.2M sold.

Rock Springs Capital Management first reported a position in CNTB in Q1 2021 and held it in 1 quarter. The position peaked at $2.2M in Q1 2021. 16 funds tracked by Wall St. Rank hold CNTB as of Q2 2021.

  • Rock Springs Capital Management reported no remaining Connect Biopharma Holdings position as of Q2 2021 after selling out during the quarter.
  • Rock Springs Capital Management sold 119,114 Connect Biopharma Holdings shares in Q2 2021, an estimated $2.2M.
  • Rock Springs Capital Management first reported a position in Connect Biopharma Holdings in Q1 2021 and held it in 1 quarter.
  • Rock Springs Capital Management's Connect Biopharma Holdings position peaked at $2.2M in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2021.

Based on Rock Springs Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.